<?xml version="1.0" encoding="UTF-8"?>
<p>The data gathered were sorted, tabulated, and subjected to appropriate statistical analysis using SAS 9.1.3 software package (Cary, NC, USA). For statistical purposes, the screening scores were considered as baseline. Results are expressed as mean ± SD or median scores. The baseline and THCs treatment data generated were compared at the two-sided 5% significance level. Paired 
 <italic>t</italic>-tests were performed to assess the changes in the safety parameters. A comparative analysis on the efficacy was further evaluated using additional statistical methods, such as Cochran's 
 <italic>Q</italic> test, McNemar test, Friedman ANOVA, and Wilcoxon signed-rank test. For all the statistical tests, 
 <italic>p</italic> &lt; 0.05 was considered significant.
</p>
